Rut Meseguer Naturil | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Best Researcher Award

Rut Meseguer Naturil
Health Research Institute INCLIVA, Spain

Rut Meseguer
Affiliation Health Research Institute INCLIVA
Country Spain
Documents 2
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-4376-5997

Rut Meseguer Naturil is a researcher affiliated with the Health Research Institute INCLIVA in Spain whose documented research output includes work in immunology and translational biomedical science. The available publication record highlights research involving natural killer (NK) cell biology, immunotherapy manufacturing, and therapeutic strategies for severe infectious disease. These contributions provide a basis for consideration within the Best Researcher Award category of the International Academic Excellence Awards.

Abstract

The research record associated with Rut Meseguer Naturil encompasses biomedical investigation relevant to immune-cell biology and translational medicine. A recent publication examines how donor NKG2A/NKG2C immunophenotypes influence the GMP-compliant manufacturing potential of NK cells for adoptive immunotherapy, connecting donor characteristics with the practical development of cellular therapeutic products [1]. Earlier work addressed combined therapeutic approaches in severe-to-critical COVID-19, contributing to the broader understanding of treatment strategies for complex infectious disease [2].

Keywords

NK cells, natural killer cells, NKG2A, NKG2C, adoptive immunotherapy, GMP manufacturing, immunology, COVID-19, translational medicine, biochemistry, molecular biology.

Introduction

Natural killer cells are an important component of the human immune system and have attracted substantial interest as candidates for cellular immunotherapy. Their therapeutic development requires reproducible manufacturing processes and careful consideration of biological variability. Research examining donor immunophenotypes can therefore help clarify factors associated with NK-cell production and downstream therapeutic applications [1].

Research Profile

The documented research profile is situated within Biochemistry, Genetics and Molecular Biology and intersects with immunology and translational biomedical research. The available record identifies two documents, while citation and h-index information has not been supplied. The publications demonstrate engagement with clinically relevant questions involving immune-cell therapies and severe infectious disease.

Research Contributions

  • Investigated donor NKG2A/NKG2C immunophenotypes in relation to GMP-compliant NK-cell manufacturing for adoptive immunotherapy [1].
  • Contributed to research evaluating rationales for combined therapies in severe-to-critical COVID-19 patients [2].
  • Connected laboratory immunology with translational considerations relevant to cellular therapy and clinical treatment strategies.

Publications

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, August 2026.[1].

Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology, September 11, 2023. [2].

Research Impact

The research addresses practical and clinically relevant questions in contemporary biomedical science. Work on GMP-compliant NK-cell manufacturing is particularly relevant to the translation of immune-cell research into standardized therapeutic products, while the COVID-19 publication contributes to the evidence base surrounding combination treatment strategies [1] [2].

Award Suitability

Rut Meseguer Naturil’s documented publications provide evidence of research activity spanning immune-cell biology, cellular therapy manufacturing, and clinical immunology. The combination of methodological and translational themes is relevant to the Best Researcher Award, particularly within the stated Biochemistry, Genetics and Molecular Biology subject area. Award assessment should consider the complete research record, including independently verifiable publications, scholarly impact, innovation, and broader contributions.

Conclusion

The available record presents Rut Meseguer Naturil as a researcher contributing to biomedical topics with relevance to immunotherapy and infectious disease. The documented studies provide a scholarly basis for recognition in the Best Researcher Award category, while further evaluation of the complete publication and impact record would provide a more comprehensive assessment.

References

  1. Meseguer Naturil, R., et al. (2026). Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, 18(17), 2732.
    https://doi.org/10.3390/cancers18172732
  2. Frontiers in Immunology. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology. PMID: 37767093; PMCID: PMC10520558.
    https://doi.org/10.3389/fimmu.2023.1232472
  3. MDPI. (2026). Cancers, Volume 18, Issue 17, Article 2732. Multidisciplinary Digital Publishing Institute.
    https://www.mdpi.com/2072-6694/18/17/2732
  4. Europe PMC. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Europe PMC record, PMCID: PMC10520558.
    https://europepmc.org/article/pmc/PMC10520558
  5. ORCID. (n.d.). Rut Meseguer Naturil — ORCID record. ORCID iD: 0000-0003-4376-5997.
    https://orcid.org/0000-0003-4376-5997
  6. International Academic Excellence Awards. (n.d.). Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

Marizia Trevizani | Biochemistry | Best Researcher Award

Dr. Marizia Trevizani | Biochemistry | Best Researcher Award

Dr. Marizia Trevizani, Federal University of Juiz de Fora, Brazil

Marizia Trevizani is a distinguished Brazilian researcher specializing in biochemistry, genetics, and biomaterials. She earned her Bachelor’s and Licentiate degrees in Biological Sciences from the Federal University of Juiz de Fora (UFJF) in 2014. She further pursued a Master’s and Ph.D. in Biological Sciences with a focus on Genetics and Biotechnology at UFJF, including a research exchange at Temple University, USA. In 2024, she completed a postdoctoral fellowship at UFJF, focusing on the development of hydrogels derived from decellularized bovine bone matrix. Currently, she is a postdoctoral researcher at UFJF, exploring biological matrices for the creation of natural biomaterials and their recellularization. Her expertise spans human and plant genetics, bioengineering, and biomaterials. Additionally, she has experience in education, having taught Biology and Science to middle and high school students from 2016 to 2023. Her research contributes to advancements in biotechnological applications in healthcare and regenerative medicine.

Professional Profile

Scopus

Orcid

Suitability for the “Research for Best Researcher Award” – Marizia Trevizani

Marizia Trevizani demonstrates a highly impressive academic trajectory, showcasing extensive research experience in both basic and applied biological sciences. Her academic background, which includes a Bachelor’s, Master’s, and Doctorate in Biological Sciences with a focus on genetics, biotechnology, and bioengineering, sets her apart as a versatile and highly qualified researcher. Her doctoral work, which explored methods of decellularization of bovine trabecular bone and hydrogel fabrication, is an innovative contribution to the field of biomaterials and tissue engineering.

Her postdoctoral work further exemplifies her expertise in biomaterials, particularly in developing natural biomaterials through biological matrices for tissue regeneration, reflecting her capacity for cutting-edge research with practical applications in healthcare. She also contributes to the scientific community by publishing significant research and is actively involved in educational initiatives, having taught biology and science to secondary school students.

🎓 Education 

Marizia Trevizani has an extensive academic background in biological sciences. She earned her Bachelor’s degree from UFJF in 2014, where she conducted research on plant cytogenetics and genome size. She pursued a Master’s in Biological Sciences (2015–2017) at UFJF, focusing on the evaluation of plant-derived peptones as fetal bovine serum substitutes in stem cell cultures. Her Ph.D. (2017–2022) at UFJF, with a research exchange at Temple University, USA, concentrated on decellularization techniques for bovine trabecular bone and hydrogel fabrication. She also holds a specialization in Biotechnology from the Metropolitan College of São Paulo (2021–2022). Further enhancing her expertise, she completed postdoctoral research at UFJF (2023–2024) in biomaterials and tissue engineering. Additionally, she has completed various specialized training programs in chromatography, 3D printing for healthcare, molecular cloning, and pharmacology. Her academic journey has equipped her with a multidisciplinary perspective in biochemistry, biotechnology, and regenerative medicine.

💼 Professional Experience

Marizia Trevizani has built a diverse career in both research and education. As a postdoctoral researcher at UFJF, she specializes in developing biomaterials from biological matrices and studying their recellularization potential. She previously completed a postdoctoral project on hydrogels derived from decellularized bovine bone. Her doctoral and master’s research also focused on biomaterials and tissue engineering, specifically in the field of biotechnological applications. Beyond academia, she has extensive teaching experience, having worked as a Biology and Science teacher for middle and high school students between 2016 and 2023. Her work also includes participation in research projects involving genetic studies of plants and humans, bioengineering, and applied biotechnology. She has attended numerous training programs, enhancing her skills in chromatography, molecular biology, and 3D bioprinting. Her expertise lies at the intersection of genetics, biotechnology, and biomedical engineering, contributing to cutting-edge advancements in regenerative medicine.

🏅 Awards and Recognition

Throughout her career, Marizia Trevizani has received recognition for her contributions to biochemistry, biomaterials, and genetics. She was awarded research fellowships from the Coordination for the Improvement of Higher Education Personnel (CAPES) during her Master’s and Ph.D. studies. Her postdoctoral research was supported by the Minas Gerais Research Foundation (FAPEMIG). She has received accolades for her contributions to genetic and biotechnological research, particularly in developing alternative biomaterials for medical applications. Her doctoral research exchange at Temple University, USA, was a prestigious achievement, allowing her to collaborate with leading scientists in tissue engineering. Additionally, she has been recognized for her work in education, having influenced numerous students as a Biology teacher. Her dedication to advancing biomaterials and regenerative medicine has earned her invitations to scientific conferences, research collaborations, and specialized training programs in biotechnology, bioengineering, and genetics.

🌍 Research Skills On Biochemistry

Marizia Trevizani possesses a diverse set of research skills in biochemistry, biotechnology, and genetics. She specializes in biomaterials development, particularly in hydrogel fabrication and decellularization techniques for tissue engineering applications. Her expertise extends to genetic analysis, including cytogenetics, genome size evaluation, and molecular cloning. She is proficient in cell culture techniques, working extensively with plant-derived peptones as alternatives to fetal bovine serum in stem cell research. Additionally, she has experience in bioengineering, 3D bioprinting, and chromatographic techniques for material characterization. She has conducted in-depth research on plant and human genetics, focusing on biotechnological applications in healthcare. Her analytical skills are complemented by her participation in multiple training programs, covering pharmacology, molecular biology, and laboratory animal sciences. Through interdisciplinary research, she continues to contribute to advancements in regenerative medicine, tissue engineering, and sustainable biomaterials.

📖 Publication Top Notes

  • Title: Effects of decellularization on glycosaminoglycans and collagen macromolecules in bovine bone extracellular matrix
    • Authors: Marizia Trevizani, Laís Lopardi Leal, Rodolpho José da Silva Barros, Flávia de Paoli, Breno Valentim Nogueira, Fabiano Freire Costa, Jair Adriano Kopke de Aguiar, Carlos Magno da Costa Maranduba
    • Citation: Trevizani, M., Leal, L. L., Barros, R. J. d. S., Paoli, F. d., Nogueira, B. V., Costa, F. F., Aguiar, J. A. K. d., Maranduba, C. M. d. C. (2025). Effects of decellularization on glycosaminoglycans and collagen macromolecules in bovine bone extracellular matrix. International Journal of Biological Macromolecules.
    • Year: 2025
    • DOI: 10.1016/j.ijbiomac.2025.141007
  • Title: Plantas alimentícias não convencionais (PANC): potencialidades para indústria farmacêutica e de alimentos
    • Authors: Samuel Honório da Silva, Felipe Kelmer Müller, Igor Rosa Meurer, Marizia Trevizani, Fabiano Freire Costa
    • Citation: Silva, S. H. d., Müller, F. K., Meurer, I. R., Trevizani, M., Costa, F. F. (2023). Plantas alimentícias não convencionais (PANC): potencialidades para indústria farmacêutica e de alimentos. Revista Gestão & Sustentabilidade.
    • Year: 2023
    • DOI: 10.36661/2596-142X.2022v4n1.14085
  • Title: Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth
    • Authors: Marizia Trevizani, Laís Lopardi Leal, João Vitor Paes Rettore, Gilson Costa Macedo, Caio César de Souza Alves,
    • Citation: Trevizani, M., Leal, L. L., Rettore, J. V. P., Macedo, G. C., Alves, C. C. d. S., Castro, S. B. R. d., Carmo, A. M. R. d., Silva, S. A. d., Maranduba, C. M. d. C., Silva, F. d. S. (2023).
    • Year: 2023